BIOMAT Database Logo BIOMAT Database Logo

Monocarboxylic-based phosphotyrosyl mimetics in the design of GRB2 SH2 domain inhibitors. 1999

T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Laboratory of Medicinal Chemistry, Division of Basic Sciences, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Three monocarboxylic-containing analogues, O-carboxymethyltyrosine (cmT, 5), 4-(carboxymethyl)phenylalanine (cmF, 6), and 4-(carboxydifluoromethyl)phenylalanine (F2cmF, 7) were utilized as phosphotyrosyl (pTyr) replacements in a high affinity B-bend mimicking platform, where they exhibited IC50 values of 2.5 microM, 65 microM and 28 microM, respectively, in a Grb2 SH2 domain Biacore binding assay. When a terminal N(alpha)-oxalyl axillary was utilized to enhance ligand interactions with a critical SH2 domain Arg67 residue (alphaA-helix), binding potencies increased from 4- to 10-fold, resulting in submicromolar affinity for cmF (IC50 = 0.6 microM) and low micromolar affinity for F2cmF (IC50 = 2 microM). Cell lysate binding studies also showed inhibition of cognate Grb2 binding to the p185erbB-2 phosphoprotein in the same rank order of potency as observed in the Biacore assay. These results indicate the potential value of cmF and F2cmF residues as pTyr mimetics for the study of Grb2 SH2 domains and suggest new strategies for improvements in inhibitor design.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002264 Carboxylic Acids Organic compounds containing the carboxy group (-COOH). This group of compounds includes amino acids and fatty acids. Carboxylic acids can be saturated, unsaturated, or aromatic. Carboxylic Acid,Acid, Carboxylic,Acids, Carboxylic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D048868 Adaptor Proteins, Signal Transducing A broad category of carrier proteins that play a role in SIGNAL TRANSDUCTION. They generally contain several modular domains, each of which having its own binding activity, and act by forming complexes with other intracellular-signaling molecules. Signal-transducing adaptor proteins lack enzyme activity, however their activity can be modulated by other signal-transducing enzymes Signal Transducing Adaptor Proteins
D051380 GRB2 Adaptor Protein A signal transducing adaptor protein that links extracellular signals to the MAP KINASE SIGNALING SYSTEM. Grb2 associates with activated EPIDERMAL GROWTH FACTOR RECEPTOR and PLATELET-DERIVED GROWTH FACTOR RECEPTORS via its SH2 DOMAIN. It also binds to and translocates the SON OF SEVENLESS PROTEINS through its SH3 DOMAINS to activate PROTO-ONCOGENE PROTEIN P21(RAS). Growth Factor Receptor-Bound Protein-2,Abundant Src Homology Protein,GRB2 Adaptor Protein, Grb3-3 Isoform,Grb3-3 Adaptor Protein,GRB2 Adaptor Protein, Grb3 3 Isoform,Growth Factor Receptor Bound Protein 2
D018716 Molecular Mimicry The structure of one molecule that imitates or simulates the structure of a different molecule. Antigenic Mimicry,DNA Mimicry,Mimicry, Molecular,Antigen Mimicry,Antigen Mimicries,Antigenic Mimicries,DNA Mimicries,Mimicries, Antigen,Mimicries, Antigenic,Mimicries, DNA,Mimicries, Molecular,Mimicry, Antigen,Mimicry, Antigenic,Mimicry, DNA,Molecular Mimicries
D018909 src Homology Domains Regions of AMINO ACID SEQUENCE similarity in the SRC-FAMILY TYROSINE KINASES that fold into specific functional tertiary structures. The SH1 domain is a CATALYTIC DOMAIN. SH2 and SH3 domains are protein interaction domains. SH2 usually binds PHOSPHOTYROSINE-containing proteins and SH3 interacts with CYTOSKELETAL PROTEINS. SH Domains,SH1 Domain,SH2 Domain,SH3 Domain,src Homology Region 2 Domain,Homology Domain, src,Homology Domains, src,SH Domain,SH1 Domains,SH2 Domains,SH3 Domains,src Homology Domain

Related Publications

T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Design and synthesis of conformationally constrained Grb2 SH2 domain binding peptides employing alpha-methylphenylalanyl based phosphotyrosyl mimetics.
February 2005, Journal of medicinal chemistry,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Synthesis and Biochemical Evaluation of Monocarboxylic GRB2 SH2 Domain Inhibitors.
January 2023, Methods in molecular biology (Clifton, N.J.),
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Nonhydrolyzable phosphotyrosyl mimetics for the preparation of phosphatase-resistant SH2 domain inhibitors.
May 1994, Biochemistry,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Synthesis and structural characterization of a monocarboxylic inhibitor for GRB2 SH2 domain.
November 2021, Bioorganic & medicinal chemistry letters,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Structure-based design of peptidomimetic ligands of the Grb2-SH2 domain.
October 1998, Bioorganic & medicinal chemistry letters,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Highly potent inhibitors of the Grb2-SH2 domain.
January 1999, Bioorganic & medicinal chemistry letters,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Utilization of 3'-carboxy-containing tyrosine derivatives as a new class of phosphotyrosyl mimetics in the preparation of novel non-phosphorylated cyclic peptide inhibitors of the Grb2-SH2 domain.
February 2006, Organic & biomolecular chemistry,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Preliminary crystallographic characterization of the Grb2 SH2 domain in complex with a FAK-derived phosphotyrosyl peptide.
February 2010, Acta crystallographica. Section F, Structural biology and crystallization communications,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Structure-based design of a non-peptidic antagonist of the SH2 domain of GRB2.
July 1999, Bioorganic & medicinal chemistry letters,
T R Burke, and J Luo, and Z J Yao, and Y Gao, and H Zhao, and G W Milne, and R Guo, and J H Voigt, and C R King, and D Yang
Structure-based design of thioether-bridged cyclic phosphopeptides binding to Grb2-SH2 domain.
March 2003, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!